Cbl-b silenced human NK cells respond stronger to cytokine stimulation

por Lametschwandtner, Guenther, Sachet, Monika, Haslinger, Isabella, Mühleisen, Hannes, Loibner, Hans
Publicado 2015

Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors

por Triozzi, Pierre, Kooshki, Mitra, Alistar, Angela, Bitting, Rhonda, Neal, Amy, Lametschwandtner, Guenther, Loibner, Hans
Publicado 2015

Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing

por Sachet, Monika, Lametschwandtner, Guenther, Hayden, Hubert, Hassler, Michaela, Loibner, Hans, Triozzi, Pierre, Friedl, Josef
Publicado 2015

Overcoming immune-cell unresponsiveness in cancer

por Lametschwandtner, Guenther, Ermann, Monika, Sternberger, Ina, Hesterkamp, Thomas, Haslinger, Isabella, Mühleisen, Hannes, Schuster, Manfred, Loibner, Hans
Publicado 2013

Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy

por Lametschwandtner, Guenther, Loibner, Hans, Sachet, Monika, Hayden, Hubert, Hassler, Michaela, Schuster, Manfred, Salzberg, Marc, Triozzi, Pierre, Friedl, Josef
Publicado 2014